In conclusion, the role of MTH1 biology in tumors is still in its nascent stages and the utility of its therapeutic inhibition, the proverbial current “elephant in the room”, cannot be evaluated without a comprehensive understanding of the complex molecular factors that governs its function in tumor cells (Figure 2). This evidence concerns the gene NUDT1 and neoplasm.